Clinical Trials Logo

Supracondylar Humerus Fracture clinical trials

View clinical trials related to Supracondylar Humerus Fracture.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04288206 Recruiting - Infection Clinical Trials

Supracondylar Pinning Antibiotic Stewardship (SPAS) Trial

SPAS
Start date: January 7, 2021
Phase: N/A
Study type: Interventional

Prospective, multi-center, randomized controlled trial studying infection rate with or without prophylactic antibiotics at the time of closed reduction and percutaneous pinning of pediatric supracondylar humerus fractures.

NCT ID: NCT04122781 Recruiting - Clinical trials for Supracondylar Humerus Fracture

Treatment of Pediatric Supracondylar Humeral Fractures With Novel Kirschner Wire Fixation Devices

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

A novel K-wire external fixation device was developed by the investigators. The K-wires can be connected by the device. After connection, the structure of the K-wires is transformed to an external skeletal fixator. Therefore, the K-wires are stabilized and unable to migrate independently. The stability of fracture fixation is better in patient with this K-wire external fixation device. The purposes of this study are to optimize the K-wire external fixation device and test its function in real clinical practice.

NCT ID: NCT03759028 Recruiting - Clinical trials for Supracondylar Humerus Fracture

Supracondylar Post-Operative Pain Study

Start date: February 26, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study to investigate post-operative pain control in pediatric patients with closed supracondylar humerus fracture who undergo closed reduction and percutaneous pinning. Currently, it is standard of care that patients receive a narcotic prescription for post-operative pain control. All patients will initially be seen in our pediatric urgent care and recruited at the time of surgery. Patients will be randomized to receiving acetaminophen and ibuprofen or acetaminophen and oxycodone. Parents will not be blinded to the acetaminophen but both investigators, parents and the patients will be blinded to the study drug (ibuprofen or oxycodone). Pain level will be assessed using the Wong-Baker FACES scale and parents will be asked to fill out a questionnaire regarding their satisfaction with the surgery and pain control. Parents will also fill out a medication log until the patient no longer requires pain medication. The duration of participation in the study is approximately 1 week and requires 2 visits (time of recruitment at surgery to 1st post-op visit). This study is being conducted in hopes of reducing opioid prescription after surgical fixation of uncomplicated supracondylar humerus fractures if our study can show that patient's pain levels post-operatively and parent/patient satisfaction are unchanged or improved in the acetaminophen and ibuprofen arm.